semaglutide grapevine in & Southlake TX GLP-1s | AgelessRx

Accessed February 5, 2025

How liraglutide and semaglutide are used in weight management Though originally developed for patients with type 2 diabetes, GLP-1 receptor agonists are now FDA-approved for weight management in adults with a body mass index (BMI) of 30 or higher, or 27 or higher with weight related health conditions

What is Obesity

Compounded GLP-1s helped people continue treatment while brand-name GLP-1 injections were in shortage

Clinical studies demonstrate that semaglutide achieves glycemic control with HbA1c reductions of 1.5% to 1.8% at antidiabetic doses (Ozempic 0.5-1.0 mg, Rybelsus 7-14 mg) and produces weight loss ranging from 5-10% in type 2 diabetes and 12-15% with higher doses (Wegovy 2.4 mg) in patients with obesity